National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1435441

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 7/2/2021

VAERS ID: 1435441
VAERS Form:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other      Purchased by: ??
Symptoms: Acute myocardial infarction

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-06-11
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Diabetes mellitus; Hyperlipidaemia; Hypertension
Diagnostic Lab Data:
CDC 'Split Type': JPPFIZER INC2021756611

Write-up: This is a spontaneous report from a contactable physician. On 07Jun2021, a male patient in his 60s received the first dose of BNT162b2 (COMIRNATY, Solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration at single dose for COVID-19 immunisation. The patient had underlying diseases of hypertension, hyperlipidaemia and diabetes mellitus. On 11Jun2021, when the patient was doing yard work on a garden, he fell down and he was transferred to a hospital by an ambulance. On the same day at 11:44, the patient''s death was confirmed. Outcome of event was fatal.The cause of death was acute myocardial infarction. It was not reported if an autopsy was performed. The causal relationship with BNT162b2 was unknown.; Sender''s Comments: Based on the limited information in the case report and a plausible temporal relationship, A possible causal relationship between event Acute Myocardial Infarction and suspect drug BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: Acute myocardial infarction

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166